John Leachman is a veteran finance and sales executive and one of Harbright’s three founding partners. At Harbright, John has led or co-led med tech investments in Ascyrus (acquired by CryoLife), SonoVascular, VQ Biomedical, Agilix Health, Deep Blue Medical, PLU Ophthalmic, and Lumata. His board involvement includes serving on the board of Flux Hybrids, previously on the board of Chekhub, and as an observer for SonoVascular.
He holds a Master of Business Administration degree from Duke University’s Fuqua School of Business, with a focus on Life Science Product Strategy, Accounting, and Finance, and a Bachelor of Business Administration from the University of Kentucky.
Based in Atlanta, GA, he and his wife, Dr. Brooke Leachman, are kept busy by their four children.
